IL152957A0 - 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity - Google Patents

16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity

Info

Publication number
IL152957A0
IL152957A0 IL15295701A IL15295701A IL152957A0 IL 152957 A0 IL152957 A0 IL 152957A0 IL 15295701 A IL15295701 A IL 15295701A IL 15295701 A IL15295701 A IL 15295701A IL 152957 A0 IL152957 A0 IL 152957A0
Authority
IL
Israel
Prior art keywords
estrogenic activity
steroid compounds
selective estrogenic
carbocyclic condensed
carbocyclic
Prior art date
Application number
IL15295701A
Other languages
English (en)
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of IL152957A0 publication Critical patent/IL152957A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL15295701A 2000-06-06 2001-05-01 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity IL152957A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00201986 2000-06-06
PCT/EP2001/004868 WO2002000682A1 (en) 2000-06-06 2001-05-01 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity

Publications (1)

Publication Number Publication Date
IL152957A0 true IL152957A0 (en) 2003-06-24

Family

ID=8171601

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15295701A IL152957A0 (en) 2000-06-06 2001-05-01 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity

Country Status (27)

Country Link
US (3) US7868193B2 (no)
EP (1) EP1294739B1 (no)
JP (1) JP5095902B2 (no)
KR (1) KR100769865B1 (no)
CN (1) CN1235908C (no)
AR (1) AR028080A1 (no)
AT (1) ATE293124T1 (no)
AU (2) AU5838601A (no)
BR (1) BR0111445A (no)
CA (1) CA2410220C (no)
CZ (1) CZ20024014A3 (no)
DE (1) DE60110069T2 (no)
DK (1) DK1294739T3 (no)
ES (1) ES2240454T3 (no)
HK (1) HK1052012A1 (no)
HU (1) HUP0301190A3 (no)
IL (1) IL152957A0 (no)
MX (1) MXPA02012117A (no)
NO (1) NO324247B1 (no)
PE (1) PE20020214A1 (no)
PL (1) PL203732B1 (no)
PT (1) PT1294739E (no)
RU (1) RU2255090C2 (no)
SK (1) SK286852B6 (no)
TW (1) TWI225068B (no)
WO (1) WO2002000682A1 (no)
ZA (1) ZA200209452B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201109346A (en) * 2009-06-10 2011-03-16 Organon Nv Substituted 16,17-annellated steroid compounds for use in women's healthcare
US8367648B2 (en) 2009-06-10 2013-02-05 Msd Oss B.V. Substituted 16,17-annellated steroid compounds for use in womens healthcare

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3194821A (en) * 1963-12-30 1965-07-13 Abbott Lab 17alpha-substituted 17beta-hydroxyestrenes
CA2200423C (en) 1996-03-26 2006-12-19 Sietse Mosselman Novel estrogen receptor
TW403736B (en) * 1997-02-21 2000-09-01 Akzo Nobel Nv Steroid compounds having contraceptive and anti-osteoporosis activity

Also Published As

Publication number Publication date
US7868193B2 (en) 2011-01-11
EP1294739A1 (en) 2003-03-26
JP2004501931A (ja) 2004-01-22
PE20020214A1 (es) 2002-03-13
US20040102426A1 (en) 2004-05-27
NO20025793L (no) 2002-12-02
DE60110069T2 (de) 2005-09-22
KR100769865B1 (ko) 2007-10-25
AU2001258386B2 (en) 2005-08-18
HUP0301190A3 (en) 2010-03-29
NO324247B1 (no) 2007-09-17
SK17072002A3 (sk) 2003-06-03
AU5838601A (en) 2002-01-08
RU2255090C2 (ru) 2005-06-27
CA2410220A1 (en) 2002-01-03
NO20025793D0 (no) 2002-12-02
DE60110069D1 (de) 2005-05-19
CN1433426A (zh) 2003-07-30
HUP0301190A2 (hu) 2003-08-28
ZA200209452B (en) 2004-02-20
CZ20024014A3 (cs) 2003-04-16
KR20030028752A (ko) 2003-04-10
BR0111445A (pt) 2003-06-03
HK1052012A1 (en) 2003-08-29
US20100249083A1 (en) 2010-09-30
PT1294739E (pt) 2005-06-30
ATE293124T1 (de) 2005-04-15
TWI225068B (en) 2004-12-11
JP5095902B2 (ja) 2012-12-12
SK286852B6 (sk) 2009-06-05
MXPA02012117A (es) 2003-06-06
US20110224183A1 (en) 2011-09-15
CN1235908C (zh) 2006-01-11
ES2240454T3 (es) 2005-10-16
CA2410220C (en) 2009-04-28
PL359238A1 (en) 2004-08-23
PL203732B1 (pl) 2009-11-30
WO2002000682A1 (en) 2002-01-03
DK1294739T3 (da) 2005-08-01
AR028080A1 (es) 2003-04-23
EP1294739B1 (en) 2005-04-13

Similar Documents

Publication Publication Date Title
HK1051193A1 (en) (1,4')-Bipiperidine compounds.
CY2325B1 (en) Estrogenic agents.
HK1050254A1 (en) Isolated instructions for isolated execution.
MXPA01011070A (es) Derivados de esteroides.
AU4787301A (en) 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin d compounds
ZA200003927B (en) 1,2,4,5-tetrahydro-benzo[d]jazepines.
MXPA02012897A (es) Combinaciones de bisfosfonatos, agentes estrigenicos y opcionalmente estrogenos.
HK1069171A1 (en) Substituted 6H-dibenzioÄc,hÜchromenes as estrogenic agents.
ZA993345B (en) Nefazodone dosage form.
ZA200108968B (en) New compounds.
PL362982A1 (en) Benzothiophene derivative compounds, process for the preparation and use thereof
MXPA02012896A (es) Combinaciones de estatinas, agentes estrogenicos y opcionalmente estrogenos.
EG23909A (en) Vatamin d, analogs
IL144455A0 (en) 16-hydroxyestratrienes as selective estrogens
HK1069770A1 (en) Remedies for dermatophytosis
AU2001293512A8 (en) Aldehyde-releasing compounds
IL149424A0 (en) 14,15-beta-methylene substituted androgens
AU5838601A (en) 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity
AU3964400A (en) Selective estrogenic compounds
SI1272504T1 (sl) 8beta-hidrokarbilno substituirani estratrieni kotestrogeni s selektivnim učinkom
HK1055954A1 (en) Crystalline therapeutic agent.
ZA200300417B (en) 16alpha-methyl or ethyl substituted estrogens.
MXPA03004658A (es) Compuestos activos en el receptor glucocorticoide ii.
DK0973790T3 (da) Estra-5(10),7-diener med østrogen aktivitet
HK1042291A1 (en) Dimeric compounds.

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees